RECOMBINANT ZOSTER VACCINE

Clinical trials for RECOMBINANT ZOSTER VACCINE explained in plain language.

Never miss a new study

Get alerted when new RECOMBINANT ZOSTER VACCINE trials appear

Sign up with your email to follow new studies for RECOMBINANT ZOSTER VACCINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New shot aims to stop painful shingles outbreaks

⭐️ VACCINE ⭐️ Ongoing

This study is testing a new shingles vaccine called LYB004 to see how well it triggers an immune response and how safe it is. It will involve 840 adults in China aged 40 and older, who will receive different versions of the vaccine or a placebo. The main goal is to measure the bo…

Matched conditions: RECOMBINANT ZOSTER VACCINE

Phase: PHASE2 • Sponsor: Guangzhou Patronus Biotech Co., Ltd. • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 27, 2026 12:40 UTC

RECOMBINANT ZOSTER VACCINE

Get alerted when new RECOMBINANT ZOSTER VACCINE trials appear

New shot aims to stop painful shingles outbreaks